(Q40343246)

19 September 2017

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis (English)

1 reference

19 September 2017

8

David Dingli

1 reference

19 September 2017

21

Angela Dispenzieri

1 reference

19 September 2017

17

Robert A Kyle

1 reference

19 September 2017

4

Martha Q Lacy

1 reference

19 September 2017

11

Stephen Russell

1 reference

19 September 2017

18

S Vincent Rajkumar

1 reference

19 September 2017

3

Morie A Gertz

1 reference

19 September 2017

6

Suzanne R Hayman

1 reference

19 September 2017

16

Steven R Zeldenrust

1 reference

19 September 2017

9

John A Lust

1 reference

19 September 2017

14

Taxiarchis Kourelis

1 reference

19 September 2017

5

Francis K Buadi

1 reference

19 September 2017

2

Shaji K Kumar

1 reference

19 September 2017

15

Wilson Gonsalves

1 reference

19 September 2017

13

Ronald S Go

1 reference

19 September 2017

12

Prashant Kapoor

1 reference

19 September 2017

1

Rahma Warsame

1 reference

19 September 2017

Nelson Leung

7

1 reference

19 September 2017

Yi Lin

series ordinal

10

1 reference

19 September 2017

Tyler Zemla

series ordinal

19

1 reference

19 September 2017

Jeffrey Sloan

series ordinal

20

1 reference

19 September 2017

9 February 2017

1 reference

American Journal of Hematology

19 September 2017

1 reference

19 September 2017

92

1 reference

19 September 2017

5

1 reference

19 September 2017

435-440

1 reference

PRO development: rigorous qualitative research as the crucial foundation

19 September 2017

1 reference

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

21 January 2018

1 reference

Assessing health-related quality of life in palliative care: comparing patient and physician assessments.

21 January 2018

1 reference

The missing voice of patients in drug-safety reporting

21 January 2018

1 reference

Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.

21 January 2018

1 reference

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

21 January 2018

1 reference

Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial

21 January 2018

1 reference

The patient's perspective on the symptom and everyday life impact of AL amyloidosis

21 January 2018

1 reference

Currents concepts on the immunopathology of amyloidosis

21 January 2018

1 reference

Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients

21 January 2018

1 reference

Autologous stem cell transplantation for primary systemic amyloidosis

21 January 2018

1 reference

Reviewing and selecting outcome measures for use in routine practice.

21 January 2018

1 reference

The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: a literature review

21 January 2018

1 reference

Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice

21 January 2018

1 reference

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

21 January 2018

1 reference

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

21 January 2018

1 reference

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium

21 January 2018

1 reference

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

21 January 2018

1 reference

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

21 January 2018

1 reference

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

21 January 2018

1 reference

The prognostic significance of patient-reported outcomes in cancer clinical trials

21 January 2018

1 reference

21 January 2018

1 reference

Who should measure quality of life, the doctor or the patient?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.24676

1 reference

19 September 2017

1 reference